Conbercept for patients with age-related macular degeneration: a systematic review
Abstract Background Conbercept is a novel vascular endothelial growth factor (VEGF) inhibitor for the treatment of wet age-related macular degeneration (AMD). This systematic review aims to assess the efficacy and safety of conbercept in the treatment of wet AMD. Methods PubMed, Embase, Cochrane Lib...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2018-06-01
|
| Col·lecció: | BMC Ophthalmology |
| Matèries: | |
| Accés en línia: | http://link.springer.com/article/10.1186/s12886-018-0807-1 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|